NCT03333707 is a NA clinical trial of Pacifica App in Anxiety, sponsored by Pacifica Labs Inc..

Who is sponsoring NCT03333707?

NCT03333707 is sponsored by Pacifica Labs Inc..

What drugs are being tested in NCT03333707?

Interventions in NCT03333707: Pacifica App.

What condition does NCT03333707 study?

NCT03333707 studies Anxiety, Stress, Depression.

Is NCT03333707 still recruiting?

NCT03333707 is currently completed. Last updated 17 May 2018.

Last reviewed 2018-05-17 · How we verify

NCT03333707

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of a Mobile Application (Pacifica) on Stress, Anxiety, and Depression

Completed NA Last updated 17 May 2018

What this trial tests

NA trial testing Pacifica App in Anxiety in 500 participants. Completed in 10 May 2018.

Timeline

2 November 2017

Primary endpoint
10 May 2018

10 May 2018

Quick facts

Lead sponsor	Pacifica Labs Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	none
Primary purpose	treatment
Enrollment	500
Start date	2 November 2017
Primary completion	10 May 2018
Estimated completion	10 May 2018
Sites	1 location across United States

Drugs / interventions tested

Pacifica App

Conditions studied

Anxiety — all drugs for Anxiety →
Stress — all drugs for Stress →
Depression — all drugs for Depression →

Sponsor

Pacifica Labs Inc.

Who can join

18 and older, any sex, with Anxiety or Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is designed to examine the efficacy of a mobile application implementation of existing best practices in mental health treatment for managing stress, anxiety, and depression.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Guided Self-Help Works: Randomized Waitlist Controlled Trial of Pacifica, a Mobile App Integrating Cognitive Behavioral Therapy and Mindfulness for Stress, Anxiety, and Depression.
Moberg C, Niles A, Beermann D. · · 2019 · cited 87× · PMID 31199319 · DOI 10.2196/12556

Verify or expand the search:

Other recruiting trials for Anxiety

Currently open trials in the same condition.

NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety · NA · recruiting
NCT07466875 — Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients · NA · recruiting
NCT07425951 — Building Cognitive Behavioural Skills With StoryBooks to Reduce Emotional Difficulties in Kindergarten Years · NA · recruiting
NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03333707 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Pacifica Labs Inc.
Last refreshed: 17 May 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03333707.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing